You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Outcome data concerning PRS stratified by the Heidelberg score; subgroups with and without bevacizumab are shown

From: Validation of the prognostic Heidelberg re-irradiation score in an independent mono-institutional patient cohort

Heidelberg score/group Entire cohort, PRS [months] Bevacizumab, PRS [months] No bevacizumab, PRS [months]
Excellent 7 7 --
Good 7 8 2
Moderate 9 9 --
Poor 7 8 6
P-value ns (p = 0.664) ns (p = 508) ns (p = 0.316)
  1. A “poor” score consists of patients with score values of 3 or 4.